Cargando…
Application of Artificial Intelligence in the Management of Pancreatic Cystic Lesions
The rate of incidentally detected pancreatic cystic lesions (PCLs) has increased over the past decade and was recently reported at 8%. These lesions pose a unique challenge, as each subtype of PCL carries a different risk of malignant transformation, ranging from 0% (pancreatic pseudocyst) to 34–68%...
Autores principales: | Rangwani, Shiva, Ardeshna, Devarshi R., Rodgers, Brandon, Melnychuk, Jared, Turner, Ronald, Culp, Stacey, Chao, Wei-Lun, Krishna, Somashekar G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221027/ https://www.ncbi.nlm.nih.gov/pubmed/35735595 http://dx.doi.org/10.3390/biomimetics7020079 |
Ejemplares similares
-
Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma
por: Jiang, Joanna, et al.
Publicado: (2023) -
Recent advances in the diagnostic evaluation of pancreatic cystic lesions
por: Ardeshna, Devarshi R, et al.
Publicado: (2022) -
An update on EUS-guided ablative techniques for pancreatic cystic lesions
por: Ardeshna, Devarshi R., et al.
Publicado: (2022) -
Update on endoscopic ultrasound-guided liver biopsy
por: Rangwani, Shiva, et al.
Publicado: (2022) -
Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes
por: Ardeshna, Devarshi R., et al.
Publicado: (2022)